S100A9 and ovarian carcinoma: By contrast, S100A7 shows a much wider expression pattern than S100A9, but despite its ability to promote cell proliferation, migration, invasion, and tumor metastasis in cervical, breast, and ovarian cancer [42,43,44,45], S100A7 has not previously been implicated in melanoma pathogenesis.